Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022
Ruth Offergeld(Robert Koch Institute), Matthias an der Heiden(Robert Koch Institute), Julia Ohme(German Red Cross), Andreas Nitsche(Altera (United States)), Christian Drosten(Humboldt-Universität zu Berlin), Ulrich J. Sachs(Justus-Liebig-Universität Gießen), Carlos Luis Jiménez Klingberg(German Red Cross), Karina Preußel(Robert Koch Institute), Silke Martin(German Red Cross), Peter A. Horn(University of Duisburg-Essen), Sven Peine(Universität Hamburg), Martin Schlaud(Robert Koch Institute), Konstanze Aurich(Universitätsmedizin Greifswald), Monika Lindemann(Essen University Hospital), Tanja Vollmer(Heart and Diabetes Center North Rhine-Westphalia), Malte Ziemann, David Juhl, Barbara I. Baumann-Baretti, Hannelore Neuhauser(Robert Koch Institute), Hendrik Wilking, Viktoria Dienst, Sandra Ciesek(Goethe University Frankfurt), Sebastian Haller(Robert Koch Institute), Franz F. Wagner(DRK-Blutspendedienst Baden-Württemberg - Hessen), Richard Schäfer(Goethe University Frankfurt), Natalie Hofmann(Robert Koch Institute), Marlow Zimmermann(Robert Koch Institute), Ilay Gülec(German Red Cross), Lars Schaade(Robert Koch Institute), Victor M. Corman(Humboldt-Universität zu Berlin), Andreas Greinacher(Universitätsmedizin Greifswald), Lothar H. Wieler(Hasso Plattner Institute), Michael Schmidt(Johannes Wesling Klinikum Minden), Heinrich Scheiblauer(Paul Ehrlich Institut), Claudia Houareau(Robert Koch Institute), T. Zeiler, Hans‐Gert Heuft(Medizinische Hochschule Hannover), Markus Umhau(University of Freiburg), Siegfried Görg(University of Lübeck), Marica Grossegesse(Robert Koch Institute)
Cited by 21
Related Papers
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
|The Lancet|2016|2.7k
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|Science|2003|2.6k
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k